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Objective: The present study aimed at investigating whether non-surgical periodontal treatment can reduce the
Haemoglobin A1c (HbA1c) % level in type 2 diabetic patients.
Methods: A search of the literature on English publications was performed in Cochrane Central, Medline, ISI Web of
Knowledge and EMBASE (until 06 February 2014). An RCT was selected if the subject was type 2 diabetic patients
diagnosed with chronic periodontitis, and compared HbA1c% change after non-surgical periodontal treatment
alone for at least three months of the study duration. Weighted mean difference for pooled data and large sample
size strata were calculated. Heterogeneity and publication bias were explored.
Results: After the study selection process, only 9 RCTs were suitable. Compared to the control group, the pooled
analysis (n=1082) showed −0.27 % (95 % CI:-0.46 % to −0.07 %, p= 0.007) absolute difference in HbA1c % with
treatment while studies with sufficient sample size had HbA1c % change of −0.014 % (95 % CI:-0.18 % to 0.16 %,
p= 0.87). Publication bias was marginally significant with Egger’s teat (p=0.045) but not with Begg’s test (p=0.72).
Conclusion: The moderate reduction in HbA1c after the non-surgical therapy in patients with type 2 diabetes is
consistent with previous systematic reviews. However, more large scale and high-quality RCTs are necessitated to
confirm these results.
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Recently the relationship between diabetes mellitus and
chronic periodontitis has attracted the attention of re-
searchers worldwide. Many studies suggested a two-way
relationship between diabetes mellitus and chronic peri-
odontitis [1–5]. Poor glycemic control can induce the in-
creased risk of periodontal disease or of its greater severity
in patients with diabetes. Accordingly, DM2 (type 2 dia-
betes mellitus) is considered as one of the risk factors of
periodontal disease [6, 7]. Enhanced glycemic control can
alleviate the pathological progress of the periodontal dis-
ease [8, 9].
Periodontitis is diagnosed when there is gingival in-
flammation, periodontal ligament and alveolar bone loss,* Correspondence: yangjx13@163.com
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medium, provided the original work is proper
(http://creativecommons.org/publicdomain/zeroand apical migration of junctional epithelium [10, 11].
Clinical manifestations include increased probing pocket
depth or clinical attachment loss. Therapies for periodon-
titis are composed of oral hygiene instruction, scaling, root
planing, antibiotics, chlorhexidine, surgical treatment, or a
combination of these [12].
The DM2 is regarded nowadays as a worldwide epidemic.
According to the WHO(World Health Organization)
the global upcoming estimative of the number of people
with DM2 will reach 366 million in the year 2030 [13].
DM2 (a metabolic disease resulting from defects in insulin
production, insulin activity, or both) can cause micro-
and macrovascular complications. Glycemic control is
crucial in preventing complications [14–17]. HbA1c
represents serum glucose levels during the 120-day life
of the red blood cell, and is a robust indicant of gly-
cemic control [18].distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
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positive effect of non-surgical periodontal treatment on
glycemic control despite lack of homogeneity and ro-
bustness among studies [19–22]. Since then, some new
randomized controlled trials have been done. Therefore,
it is time to provide an update to accumulate more evi-
dence and evaluate the potential effect of non-surgical




Four databases (Cochrane CENTRAL, ISI Web of Sci-
ence, MEDLINE (via PubMed) and EMBASE) have
been systematically searched using the search terms
[see Additional file 1], from their inception to 01 April
2015. Moreover, a manual search was performed from
the last 20 years of the following journals: Journal of
Periodontology, Journal of Dental Research, Journal of
Clinical Periodontology, Journal of Periodontal Re-
search, Journal of Dentistry, Journal of the American
Dental Association, Periodontology 2000, Journal of
Clinical Dentistry, Clinical Oral Investigations, ClinicalFig. 1 Flow Chart for the systematic review and meta-analysisDiabetes, Diabetologia, Diabetes, Diabetes Care, and
Diabetes Research and Clinical Practice. To be as compre-
hensive as possible, the reference lists of the searched pub-
lications were thoroughly cross-checked to avoid omission
of relevant studies.
Study selection criteria
The following inclusion criteria had to be met: (1) ran-
domized controlled clinical trial (RCT); (2) population:
type 2 diabetes mellitus diagnosed with periodontitis; (3)
non-surgical periodontal treatment without adjunctive
use of local drug delivery and systemic antibiotics at
least 3 months of follow-up; (4) control group with no
periodontal treatment or delayed treatment; (5) out-
come: mean change in HbA1c level; and(6) only pub-
lished studies in the English language were considered
for inclusion.
The Cochrane Handbook for Systematic Reviews of
Interventions (Version 5.1.0) was used as a guideline for
the selection process [23]. All retrieved articles were
evaluated by four independent reviewers (QL, HS, JF
and JXY). Disagreements were resolved by consensus.
Figure 1 showed the reasons for exclusion. Since the
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tries were removed.
After excluding articles ineligible for the study, the
relevance of all articles were screened from the titles and
abstracts. Full-text articles were assessed while articles
which did not meet the pre-specified inclusion criteria
were excluded.
Methodological study quality assessment
Study quality was evaluated independently by two authors
(HS and JF) with the following parameters, which were:
(1) random sequence generation; (2) allocation conceal-
ment; (3) incomplete data outcome; (4) blinding; and (5)
intention-to-treat analysis, as previously described [20].
Data extraction
Four authors (QL, HS, JF and JXY) independently ex-
tracted data from each RCT in pre-designed forms. Any
disagreements were resolved by consensus. From all
relevant studies, the key parameters including demo-
graphics of the population, study quality, intervention in
the control and treatment groups, follow-up duration
and design, mean change of HbA1c levels in both groups
were recorded. When not reported, the absolute differ-
ence of HbA1c level was calculated by extracting the
mean change of HbA1c in the control group and the
mean change of HbA1c in the intervention group.
Standard deviation of the mean change of HbA1c level
from baseline to follow-up was calculated according to a
method previously described [24].
Statistical analysis
All data for meta-analysis were submitted to STATA
12.0(Texas, USA). A meta-analysis was conducted, com-
paring the intervention group with non-surgical peri-
odontal treatment and the control group which received
no periodontal treatment or delayed treatment.
For a particular multi-arm study, the treatment group
fulfilling the selection criteria for pair-wise comparison
were included [23]. Thus, only the intervention group
and control group contrasting non-surgical periodontal
treatment alone versus no treatment/delayed treatment
will be used for data analysis.
Weighted mean difference was calculated using a ran-
dom effect model (Dersimonian-Laird method) from the
included RCTs. In addition, the significant heterogeneity
was assessed by chi-square test for homogeneity (Cochran
Q-statistic and P-value), as well as I-squared statistic and
95 % CI of the I2. Publication bias was estimated by Begg’s
test, Egger’s test and funnel plot.
Results
The initial search from the four databases retrieved 247
articles, after removal of duplicates. The titles andabstracts of these studies were evaluated for inclusion,
and the reasons for exclusion are showed in Fig. 1. Of
these articles, only 52 articles were identified for full-
text reading. Finally, a total of 9 RCTs were considered
for the meta-analysis. No additional studies were identi-
fied by cross-checking the bibliographies of relevant and
retrieved articles.Study characteristics
The characteristics of the 9 RCTs are listed in Table 1.
All studies included were randomized controlled trials
[25–33].The The mean age of subjects in the included
studies ranged from 52.8 to 62.7 years. All selected studies
are of subjects having both DM2 and chronic periodon-
titis. Scaling and root planning/curettage/debridement
were regarded as the basic non-surgical periodontal treat-
ment for the intervention group in all studies. In Singh
et al., group B (n=15) was excluded for the meta-analysis
because the adjunctive systemic doxycycline (100 mg daily
for 14 days) was administrated [29].Methodological study quality assessment
Risk of bias was assessed for each selected study by the
following parameters, which are: random sequence gen-
eration, allocation concealment, blinding of participants
and personnel, incomplete data outcome and intention-
to-treat analysis. (Table 2). Only Engebretson et al. and
Koromantzos et al. reported implementing intention-to-
treat analysis [27, 31]. Allocation concealment was not
observed in 3 studies [25–27].Pooled analysis
A statistically significant difference in HbA1c reduction
was seen in the pooled analysis (Fig. 2) between the
intervention and control groups (p= 0.007), with an ef-
fect size of −0.27 % (95 % CI:-0.46 % to −0.07 %).Exploration of heterogeneity
The heterogeneity (I2) among the 9 studies was 41.7 %
(X2 =15.43, p=0.080), which suggested moderate
heterogeneity.
Since sample size was identified as a potential source
of heterogeneity, then subgroup analysis was conducted.
Non-surgical periodontal intervention with small sample
size (n<80) showed a significant improvement (p=0.005)
of HbA1c level [−0.46 % (95 % CI:-0.79 % to −0.14 %)].
Also, the heterogeneity among studies was moderate
(x2= 9.64,p=0.086, I2=48.2 %)(25,27-30). However, this
improvement was not significant (p=0.65) with large
sample size trials, with HbA1c % change of 0.01 % (95 %
CI:-0.18 % to 0.16 %, p= 0.87) [26, 31, 32].
Table 1 The characteristics of the included studies
Study Year Country Number(n) Interventions Mean age years(SD) Mean baseline Follow-up Study design
and detailMale % HbA1c % (SD) time(months)
Total C Tx1 Tx2 C Tx1 Tx2 C Tx1 Tx2































2012 Greece 60 30 30 Control:supragingival
cleaning Tx:SRP in
two sessions























59.3(10.8) 56.3 52.8(10.36) 48.8 8.08(0.78) 7.93(0.78) 8.33(0.72) 3 RCT Single
centre
Zhang et al. 2013 China 71 22 49 Control:no treatment
Tx:SRP







2013 USA 514 257 257 Control:no treatment
Tx:SRP+mouthwash






Gay IC et al. 2014 USA 126 66 60 Control:oral hygiene
instruction Tx1:
scaling +SRP




2014 Malaysia 32 17 15 Control:oral hygiene
instruction Tx1:
scaling +SRP






















Kiran 2005 ? ? ? + ? +
Chen 2012 + ? + + - +
Moeintaghavi
2012
+ ? ? + ? +
Koromantzos
2012
+ + + + + +
Singh 2008 ? - + + ? +
Zhang 2013 + + + + - +
Engebretson
2013
+ + + + + +
Gay IC 2014 + + + + + +
Raman RP 2014 + ? ? + ? +
+ adequate, ? unclear, − inadequate
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Visual inspection of the funnel plot revealed an asym-
metrical distribution (Fig. 3). In Egger’s test, the inter-
cept value of the y-axis was negative (−2.37). The
publication bias was marginally significant in Egger’s test
(p=0.045), therefore caution should be taken to get the
conclusion of no small-study effects. However, Begg’s
test was not statistically significant (p=0.72).
Discussion
This review updates a previous systematic review [19]
that was published in 2013, due to an increase of someFig. 2 Forest plot of comparison: Periodontal Therapy outcome: Change innew large-sample RCTs in this subject. This one con-
tains all previous RCTs [25–29] in that review, and new
studies meeting the inclusion criteria have been added.
In all, nine randomized clinical trials [25–33] are re-
trieved, with two new studies [30, 31] meet the selection
criteria established by Sgolastra et al. [19]. Now the total
number of the population of this meta-analysis amount
to 1082, nearly three times the subjects of the meta-
analysis by Sgolastra et al. [19]. It is noteworthy that the
standard deviation of the HbA1c reduction ranges in the
present analysis from 0.12 to 2.87, which is consistent
with previous reviews [19–22].HbA1c (%HbA1c) at 3 months
Fig. 3 Funnel plot of comparison: periodontal therapy outcome: change in HbA1c
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0.46,-0.07) observed among all nine studies remains statis-
tically significant, which is consistent with the two recent
systematic reviews [−0.36 % HbA1c,CI:-0.54,-0.19][21]and
[−0.65 % HbA1c, CI:-0.43,-0.88] [19]. Therefore, the
present meta-analysis seemingly reaches the conclusion
that non-surgical periodontal intervention may reduce the
HbA1c level [19]. However, caution should be taken to in-
terpret the data as the heterogeneity among studies was
margionally significant (p=0.080).
When stratified by sample size (Fig. 2), the analysis
showed that trials with small sample size (n<80) demon-
strated effective improvement of glycemic control, redu-
cing 0.46 % HbA1c level compared with no treatment
[25, 27–30, 33]. The subgroup analysis of small RCTs
showed a greater effect size, partially due to the small
sample size effect(the small sample size study with larger
variance is more likely to overestimate the effect sizes
compared with large trials).
Conversely RCTs with large sample size (n>80) showed
an insignificant effect size [26, 31, 32]. While recent stud-
ies suggested that TNF-a enhanced the insulin resistance
in infection by inhibiting insulin-induced tyrosine phos-
phorylation of insulin receptor substrate-1(IRS-1) [34].
Biological plausibility could be established at this point.
Meanwhile only three trials adopted the large sample size
within the study design [26, 31, 32]. Therefore, more
large-multicenter high-quality RCTs are needed in this
area.
Furthermore, the methodological study quality was far
from ideal. For instance, per protocol analysis was done
in Chen et al. [26], Moeintaghavi et al. [28] and Zhang
et al. [30]. This could jeopardize the generation of ran-
dom sequence. The duration of treatment ranged fromthree to six months. Although all studies provided
mechanical instrumentation as non-surgical periodontal
treatment, Engebretson et al. [31] provided chlorhexi-
dine oral rinse at baseline and supportive periodontal
therapy at 3 and 6 months. Chen et al. [26] prescribed
only supragingival prophylaxis at 3 months in the treat-
ment group 3 with no debridement in deep periodontal
pockets. Discrepancies in baseline HbA1c levels, treat
regimens of DM2 and the severity of CP could also ac-
count to some extent for the heterogeneity.
The moderate effect size of the reduction of HbA1c
−0.27 % HbA1c (95 % CI:-0.46,-0.07) was observed
among all nine studies. While the clinical value of the
HbAbc-reduction can not be neglected. Non-surgical
periodontal therapy may be an adjunctive way to en-
hance glycemic control [34]. It has been suggested that 1
% reduction in HbA1c levels means 35 % decrease in
complications. It also estimated that a 10 % decrease in
mortality is associated with a 0.2 % reduction in HbA1c
[35]. Therefore, despite the modest effect size of the re-
duction of HbA1c level, non-surgical periodontal treat-
ment regimens enhances the glycemic control.
The precise pathogenesis involving CP and DM2
needs to be further investigated. Chronic periodontitis
may initiate or maintain an elevated systemic chronic
inflammation. Enhanced serum level of TNF-a, IL-6 and
IL-1 can be detected in patients diagnosed with CP and
DM2, IL-1 and IL-6 can antagonize the insulin action
and TNF-a can interfere with lipid metabolism [36].
Currently several studies have demonstrated that IL-1
antagonism [37–39] and salsalate [40] may get the im-
proved glycemic control of the DM2 with CP.
The strengths of this meta-analysis are the restriction
to non-surgical periodontal treatment alone, without the
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change of HbA1c, and the inclusion of the largest multi-
center high-quality RCT [31] since the publication of the
four reviews in 2013. The outcome suggested that more
large sample size and high-quality RCTs are needed to
confirm the conclusion.
However, some limitations in the present study should
be recognized. The small sample size within the study
could lead to the small-study effect. Furthermore, dis-
crepancies in baseline HbA1c levels, treat regimens of
DM2 and CP severity were observed among the included
studies.
In order to clarify the biological mechanism of the ef-
fect of SRP on the change of HbA1c level, it is important
that negative findings in this area should be objectively
published.
Conclusion
The meta-analysis result seems to support the effective-
ness of non-surgical periodontal treatment in the en-
hancement of glycemic control in patients with CP and
DM2. However, more large-multicenter high-quality RCTs
are needed to confirm these results.
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